Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Probiotics, particularly specific strains of Lactobacillus, show promising potential in reducing the incidence and severity of Acute Graft-Versus-Host Disease (acute GVHD) by modulating gut microbiota and immune responses.
Probiotics (living agents) like Lactobacillus rhamnosus GG reduce Bacterial Translocation / Intestinal permeability from the gut to systemic circulation, a key trigger for Acute Graft-Versus-Host Disease (acute GVHD)…